0% found this document useful (0 votes)
3 views1 page

Impact of MDR1 C3435T Silent Mutation

The C3435T silent mutation in the human MDR1 gene affects gene expression and protein function despite not altering the amino acid sequence. This mutation influences mRNA structure and translation kinetics, leading to variations in drug interaction and patient responses to medications. It highlights the importance of considering synonymous mutations in genetic studies and pharmacogenomics due to their potential physiological impacts.

Uploaded by

Joseph Muriithi
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
3 views1 page

Impact of MDR1 C3435T Silent Mutation

The C3435T silent mutation in the human MDR1 gene affects gene expression and protein function despite not altering the amino acid sequence. This mutation influences mRNA structure and translation kinetics, leading to variations in drug interaction and patient responses to medications. It highlights the importance of considering synonymous mutations in genetic studies and pharmacogenomics due to their potential physiological impacts.

Uploaded by

Joseph Muriithi
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

Silent Mutation in the Human MDR1 Gene: Implications Beyond Synonymy

Silent mutations, though often considered biologically neutral, can sometimes influence gene
expression and protein function without altering the encoded amino acid. A notable example
is the C3435T mutation found in the human MDR1 gene (also known as ABCB1), which
encodes P-glycoprotein, a key transporter responsible for pumping various drugs across cell
membranes. This protein is especially significant in drug resistance mechanisms, such as
those observed in cancer therapies.

At the molecular level, the C3435T mutation involves a cytosine (C) being replaced by
thymine (T) at position 3435 in the cDNA sequence of the gene. Despite this nucleotide
substitution, the resulting codon still codes for the amino acid leucine. Therefore, it is
categorized as a silent or synonymous mutation since it does not alter the primary sequence
of the P-glycoprotein.

However, what makes this mutation scientifically compelling is that it has been shown to
affect the gene's expression and protein folding. According to research by Kimchi-Sarfaty et
al. (2007), the presence of the T allele alters the mRNA’s secondary structure, leading to
differences in translation kinetics. These changes can result in a protein with a slightly altered
conformation, ultimately influencing substrate binding and drug interaction profiles. As a
result, patients with this variant may respond differently to medications that are substrates of
P-glycoprotein.

Although the mutation does not change the amino acid sequence, its influence on mRNA
structure and translation efficiency indicates that it is not functionally silent. Rather than
being a neutral byproduct of genetic variation, the C3435T mutation demonstrates how
synonymous changes can still have physiological consequences. This mutation may not
become nonsynonymous in the traditional sense—where one amino acid is substituted for
another—but it holds functional relevance akin to that of nonsynonymous mutations,
affecting how the protein behaves in the cellular environment.

This case reinforces the growing recognition in molecular biology that synonymous
mutations can play active roles in gene regulation, mRNA stability, and even disease
susceptibility. As such, it is crucial to consider these mutations in genetic studies and
pharmacogenomics research.

References

Ahern, K., Rajagopal, S., & Tan, P. (2018). Biochemistry Free for All (Version 1.3).
Retrieved from [Link]

Kimchi-Sarfaty, C., Oh, J. M., Kim, I. W., Sauna, Z. E., Calcagno, A. M., Ambudkar, S. V.,
& Gottesman, M. M. (2007). A “silent” polymorphism in the MDR1 gene changes substrate
specificity. Science, 315(5811), 525–528. [Link]

You might also like